Search Results 971-980 of 18377 for Hepatitis C

  1. Fever treatment: Quick guide to treating a fever - Mayo Clinic

    18 years and up, Up to 102 F (38.9 C) taken orally, Rest and drink plenty of fluids. Medication isn't needed. Call the doctor if the fever is accompanied by a ...

  2. Peter C. Lucas, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    Peter C. Lucas, M.D., Ph.D., is a pathologist and scientist at Mayo Clinic who studies oncoimmune signaling pathways in lymphoma, breast cancer and other ...

  3. Cisplatin, Intensity-Modulated Radiation Therapy, and Pembrolizumab in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma - Mayo Clinic

    Known active hepatitis B (e.g., hepatitis B surface antigen [HBsAg] reactive) or hepatitis C (e.g., hepatitis c virus [HCV] ribonucleic acid [RNA] ...

  4. Study of INCB053914 in Subjects With Advanced Malignancies - Mayo Clinic

    Evidence of hepatitis B virus (HBV) or hepatitis C virus (HCV) infection. Active and uncontrolled infectious disease requiring systemic antibiotic ...

  5. Patient Stories - Keith C. Bible, M.D., Ph.D. - Mayo Clinic

    Search for a doctor. Keith C. Bible, M.D., Ph.D. Oncologist. Request an Appointment · Overview. Patient Stories. Print. PST-20217648. Home; Patient Stories ...

  6. Head and neck cancers - Doctors and departments - Mayo Clinic

    Displaying 1-10 out of 11 doctors available. Last Name Initial: C,C,C,C,C,C,C,C,C,C,C,C,C,C,C,C. William J. Casey, III, M.D..

  7. Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial - Mayo Clinic

    * Known or suspected active hepatitis C infection. * Any medical or psychiatric illness that could, in the investigator's opinion, potentially interfere ...

  8. APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis - Mayo Clinic

    Have negative serology for hepatitis B virus (HBV) and hepatitis C virus (HCV). Exclusion Criteria: Had a prior liver transplant or is planned to undergo ...

  9. A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough (CALM-2) - Mayo Clinic

    ... hepatitis B virus surface antigen, or hepatitis C virus. - Previous participation in a BLU-5937 trial. Note: Other protocol defined Inclusion/Exclusion ...

  10. Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis - Mayo Clinic

    Subjects with a Class B or Class C Child-Pugh score. 2. Subjects with concomitant liver diseases including chronic viral hepatitis B or C, autoimmune hepatitis ...